Selected research
Market Structure
Global Serum-free Medium for Cells Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Serum-free Medium for Cells market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Serum-free Medium for Cells is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Serum-free Medium for Cells is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Serum-free Medium for Cells is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Serum-free Medium for Cells is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Serum-free Medium for Cells include BioLifeSolutions, Biological Industries, Corning Inc, Cytiva, FUJIFILM Irvine Scientific, GE Healthcare, HiMedia Laboratories, Nippon Genetics and PromoCell, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Serum-free Medium for Cells market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Serum-free Medium for Cells and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Serum-free Medium for Cells sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Serum-free Medium for Cells market size, projected growth trends, production technologies, key applications, and end-use industries.
Serum-free Medium for Cells Segment by Company
BioLifeSolutions
Biological Industries
Corning Inc
Cytiva
FUJIFILM Irvine Scientific
GE Healthcare
HiMedia Laboratories
Nippon Genetics
PromoCell
R&D Systems (Bio-Techne)
Rohto Pharmaceutical
Beijing Cellapy Biological
Beijing T&L Biotechnology
Beijing Sino Biological
Beijing Yocon Biology
Cytocraft
Thermo Fisher Scientific
Serum-free Medium for Cells Segment by Type
With DMSO
Without DMSO
Serum-free Medium for Cells Segment by Application
Research Centers
Biopharma Industry
Clinical Research Organizations
Others
Serum-free Medium for Cells Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Serum-free Medium for Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Serum-free Medium for Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Serum-free Medium for Cells.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Serum-free Medium for Cells market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Serum-free Medium for Cells manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Serum-free Medium for Cells in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Serum-free Medium for Cells in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- With DMSO
- Without DMSO
Applications
- Research Centers
- Biopharma Industry
- Clinical Research Organizations
- Others
Companies covered
- BioLifeSolutions
- Biological Industries
- Corning Inc
- Cytiva
- FUJIFILM Irvine Scientific
- GE Healthcare
- HiMedia Laboratories
- Nippon Genetics
- PromoCell
- R&D Systems (Bio-Techne)
- Rohto Pharmaceutical
- Beijing Cellapy Biological
- Beijing T&L Biotechnology
- Beijing Sino Biological
- Beijing Yocon Biology
- Cytocraft
- Thermo Fisher Scientific
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Serum-free Medium for Cells Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Serum-free Medium for Cells Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Serum-free Medium for Cells Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Serum-free Medium for Cells Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Serum-free Medium for Cells Market Dynamics
- 2.1 Serum-free Medium for Cells Industry Trends
- 2.2 Serum-free Medium for Cells Industry Drivers
- 2.3 Serum-free Medium for Cells Industry Opportunities and Challenges
- 2.4 Serum-free Medium for Cells Industry Restraints
3 Serum-free Medium for Cells Market by Manufacturers
- 3.1 Global Serum-free Medium for Cells Revenue by Manufacturers (2021-2026)
- 3.2 Global Serum-free Medium for Cells Sales by Manufacturers (2021-2026)
- 3.3 Global Serum-free Medium for Cells Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Serum-free Medium for Cells Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Serum-free Medium for Cells Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Serum-free Medium for Cells Manufacturers, Product Type & Application
- 3.7 Global Serum-free Medium for Cells Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Serum-free Medium for Cells Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Serum-free Medium for Cells Players Market Share by Revenue in 2025
- 3.8.3 2025 Serum-free Medium for Cells Tier 1, Tier 2, and Tier 3
4 Serum-free Medium for Cells Market by Type
- 4.1 Serum-free Medium for Cells Type Introduction
- 4.1.1 With DMSO
- 4.1.2 Without DMSO
- 4.2 Global Serum-free Medium for Cells Sales by Type
- 4.2.1 Global Serum-free Medium for Cells Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Serum-free Medium for Cells Sales by Type (2021-2032)
- 4.2.3 Global Serum-free Medium for Cells Sales Market Share by Type (2021-2032)
- 4.3 Global Serum-free Medium for Cells Revenue by Type
- 4.3.1 Global Serum-free Medium for Cells Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Serum-free Medium for Cells Revenue by Type (2021-2032)
- 4.3.3 Global Serum-free Medium for Cells Revenue Market Share by Type (2021-2032)
5 Serum-free Medium for Cells Market by Application
- 5.1 Serum-free Medium for Cells Application Introduction
- 5.1.1 Research Centers
- 5.1.2 Biopharma Industry
- 5.1.3 Clinical Research Organizations
- 5.1.4 Others
- 5.2 Global Serum-free Medium for Cells Sales by Application
- 5.2.1 Global Serum-free Medium for Cells Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Serum-free Medium for Cells Sales by Application (2021-2032)
- 5.2.3 Global Serum-free Medium for Cells Sales Market Share by Application (2021-2032)
- 5.3 Global Serum-free Medium for Cells Revenue by Application
- 5.3.1 Global Serum-free Medium for Cells Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Serum-free Medium for Cells Revenue by Application (2021-2032)
- 5.3.3 Global Serum-free Medium for Cells Revenue Market Share by Application (2021-2032)
6 Global Serum-free Medium for Cells Sales by Region
- 6.1 Global Serum-free Medium for Cells Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Serum-free Medium for Cells Sales by Region (2021-2032)
- 6.2.1 Global Serum-free Medium for Cells Sales by Region (2021-2026)
- 6.2.2 Global Serum-free Medium for Cells Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Serum-free Medium for Cells Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Serum-free Medium for Cells Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Serum-free Medium for Cells Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Serum-free Medium for Cells Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Serum-free Medium for Cells Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Serum-free Medium for Cells Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Serum-free Medium for Cells Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Serum-free Medium for Cells Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Serum-free Medium for Cells Revenue by Region
- 7.1 Global Serum-free Medium for Cells Revenue by Region
- 7.1.1 Global Serum-free Medium for Cells Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Serum-free Medium for Cells Revenue by Region (2021-2026)
- 7.1.3 Global Serum-free Medium for Cells Revenue by Region (2027-2032)
- 7.1.4 Global Serum-free Medium for Cells Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Serum-free Medium for Cells Revenue (2021-2032)
- 7.2.2 North America Serum-free Medium for Cells Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Serum-free Medium for Cells Revenue (2021-2032)
- 7.3.2 Europe Serum-free Medium for Cells Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Serum-free Medium for Cells Revenue (2021-2032)
- 7.4.2 Asia-Pacific Serum-free Medium for Cells Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Serum-free Medium for Cells Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Serum-free Medium for Cells Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 BioLifeSolutions
- 8.1.1 BioLifeSolutions Company Information
- 8.1.2 BioLifeSolutions Business Overview
- 8.1.3 BioLifeSolutions Serum-free Medium for Cells Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 BioLifeSolutions Serum-free Medium for Cells Product Portfolio
- 8.1.5 BioLifeSolutions Recent Developments
- 8.2 Biological Industries
- 8.2.1 Biological Industries Company Information
- 8.2.2 Biological Industries Business Overview
- 8.2.3 Biological Industries Serum-free Medium for Cells Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Biological Industries Serum-free Medium for Cells Product Portfolio
- 8.2.5 Biological Industries Recent Developments
- 8.3 Corning Inc
- 8.3.1 Corning Inc Company Information
- 8.3.2 Corning Inc Business Overview
- 8.3.3 Corning Inc Serum-free Medium for Cells Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Corning Inc Serum-free Medium for Cells Product Portfolio
- 8.3.5 Corning Inc Recent Developments
- 8.4 Cytiva
- 8.4.1 Cytiva Company Information
- 8.4.2 Cytiva Business Overview
- 8.4.3 Cytiva Serum-free Medium for Cells Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Cytiva Serum-free Medium for Cells Product Portfolio
- 8.4.5 Cytiva Recent Developments
- 8.5 FUJIFILM Irvine Scientific
- 8.5.1 FUJIFILM Irvine Scientific Company Information
- 8.5.2 FUJIFILM Irvine Scientific Business Overview
- 8.5.3 FUJIFILM Irvine Scientific Serum-free Medium for Cells Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 FUJIFILM Irvine Scientific Serum-free Medium for Cells Product Portfolio
- 8.5.5 FUJIFILM Irvine Scientific Recent Developments
- 8.6 GE Healthcare
- 8.6.1 GE Healthcare Company Information
- 8.6.2 GE Healthcare Business Overview
- 8.6.3 GE Healthcare Serum-free Medium for Cells Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 GE Healthcare Serum-free Medium for Cells Product Portfolio
- 8.6.5 GE Healthcare Recent Developments
- 8.7 HiMedia Laboratories
- 8.7.1 HiMedia Laboratories Company Information
- 8.7.2 HiMedia Laboratories Business Overview
- 8.7.3 HiMedia Laboratories Serum-free Medium for Cells Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 HiMedia Laboratories Serum-free Medium for Cells Product Portfolio
- 8.7.5 HiMedia Laboratories Recent Developments
- 8.8 Nippon Genetics
- 8.8.1 Nippon Genetics Company Information
- 8.8.2 Nippon Genetics Business Overview
- 8.8.3 Nippon Genetics Serum-free Medium for Cells Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Nippon Genetics Serum-free Medium for Cells Product Portfolio
- 8.8.5 Nippon Genetics Recent Developments
- 8.9 PromoCell
- 8.9.1 PromoCell Company Information
- 8.9.2 PromoCell Business Overview
- 8.9.3 PromoCell Serum-free Medium for Cells Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 PromoCell Serum-free Medium for Cells Product Portfolio
- 8.9.5 PromoCell Recent Developments
- 8.10 R&D Systems (Bio-Techne)
- 8.10.1 R&D Systems (Bio-Techne) Company Information
- 8.10.2 R&D Systems (Bio-Techne) Business Overview
- 8.10.3 R&D Systems (Bio-Techne) Serum-free Medium for Cells Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 R&D Systems (Bio-Techne) Serum-free Medium for Cells Product Portfolio
- 8.10.5 R&D Systems (Bio-Techne) Recent Developments
- 8.11 Rohto Pharmaceutical
- 8.11.1 Rohto Pharmaceutical Company Information
- 8.11.2 Rohto Pharmaceutical Business Overview
- 8.11.3 Rohto Pharmaceutical Serum-free Medium for Cells Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Rohto Pharmaceutical Serum-free Medium for Cells Product Portfolio
- 8.11.5 Rohto Pharmaceutical Recent Developments
- 8.12 Beijing Cellapy Biological
- 8.12.1 Beijing Cellapy Biological Company Information
- 8.12.2 Beijing Cellapy Biological Business Overview
- 8.12.3 Beijing Cellapy Biological Serum-free Medium for Cells Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Beijing Cellapy Biological Serum-free Medium for Cells Product Portfolio
- 8.12.5 Beijing Cellapy Biological Recent Developments
- 8.13 Beijing T&L Biotechnology
- 8.13.1 Beijing T&L Biotechnology Company Information
- 8.13.2 Beijing T&L Biotechnology Business Overview
- 8.13.3 Beijing T&L Biotechnology Serum-free Medium for Cells Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Beijing T&L Biotechnology Serum-free Medium for Cells Product Portfolio
- 8.13.5 Beijing T&L Biotechnology Recent Developments
- 8.14 Beijing Sino Biological
- 8.14.1 Beijing Sino Biological Company Information
- 8.14.2 Beijing Sino Biological Business Overview
- 8.14.3 Beijing Sino Biological Serum-free Medium for Cells Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Beijing Sino Biological Serum-free Medium for Cells Product Portfolio
- 8.14.5 Beijing Sino Biological Recent Developments
- 8.15 Beijing Yocon Biology
- 8.15.1 Beijing Yocon Biology Company Information
- 8.15.2 Beijing Yocon Biology Business Overview
- 8.15.3 Beijing Yocon Biology Serum-free Medium for Cells Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.15.4 Beijing Yocon Biology Serum-free Medium for Cells Product Portfolio
- 8.15.5 Beijing Yocon Biology Recent Developments
- 8.16 Cytocraft
- 8.16.1 Cytocraft Company Information
- 8.16.2 Cytocraft Business Overview
- 8.16.3 Cytocraft Serum-free Medium for Cells Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.16.4 Cytocraft Serum-free Medium for Cells Product Portfolio
- 8.16.5 Cytocraft Recent Developments
- 8.17 Thermo Fisher Scientific
- 8.17.1 Thermo Fisher Scientific Company Information
- 8.17.2 Thermo Fisher Scientific Business Overview
- 8.17.3 Thermo Fisher Scientific Serum-free Medium for Cells Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.17.4 Thermo Fisher Scientific Serum-free Medium for Cells Product Portfolio
- 8.17.5 Thermo Fisher Scientific Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Serum-free Medium for Cells Value Chain Analysis
- 9.1.1 Serum-free Medium for Cells Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Serum-free Medium for Cells Production Mode & Process
- 9.2 Serum-free Medium for Cells Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Serum-free Medium for Cells Distributors
- 9.2.3 Serum-free Medium for Cells Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst